2m 2m 2m 2m 2m 2m 2m
IN8BIO (INAB)
NASDAQ
$1.22-$0.06 (-4.77%)
Price as of Aug 21, 2026 7:31 PM EDT- $12.6MMarket Cap
- -43.36%1-Year Change
- BiotechnologyIndustry
IN8BIO (INAB)
$1.22-$0.06 (-4.77%)
INAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.28 | ||
Change | +$0.07 (+5.79%) | ||
Open | $1.23 | ||
High | $1.30 | ||
Low | $1.18 | ||
Previous Close | $1.21 | ||
Volume | 105,890 | ||
30-Day Average Volume | 72,735 | ||
1-Week Change | 16.36% | ||
1-Month Change | 3.23% | ||
1-Year Change | -43.36% | ||
3-Year Change | -96.22% | ||
5-Year Change | -99.45% | ||
Fundamentals | |||
Shares Outstanding | 9.9M | ||
Total Assets | $21.7M | ||
Market Cap | $12.6M | ||
Enterprise Value | -$5.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.8M | ||
Free Cash Flow | -$3.7M | ||
EBIT | -$4.8M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $16.2M | ||
EPS | -$0.25 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | -1 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 06/06/2025 | ||
Earnings & Revenue